Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fangyiqing Rheumatism Granules plus Methotrexate in Rheumatoid Arthritis
CTR20131816Phase 2Completed
- Sponsor
- Guizhou Liansheng Pharmaceutical
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fang yi qing feng shi granule in rheumatoid arthritis (RA), sponsored by Guizhou Liansheng Pharmaceutical. Started Mar 2014; status: completed.
02
Drugs
Fang yi qing feng shi granule
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20131816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131816.